Rabies virus and the problems of rabies vaccination in man.
The structure of rabies virus and the importance of its glycoprotein in immunization are discussed. The improvement in vaccines for use in man, culminating in the production of the human diploid vaccine is described. Nevertheless problems remain, particularly with regard to post-exposure therapy. Possible disadvantages in the use of subunit vaccines are mentioned and attention is drawn to the discovery of the rabies-related viruses.
D000917:Antibody Formation; D046508:Culture Techniques; D006801:Humans; D012328:RNA Viruses / Q000276:immunology; D011818:Rabies / Q000276:immunology / Q000517:prevention & control / Q000628:therapy; D011819:Rabies Vaccines / Q000009:adverse effects / Q000627:therapeutic use; D011820:Rabies virus / Q000254:growth & development / Q000276:immunology; D014611:Vaccination
D011819:Rabies Vaccines